ABAXIS Announces Appointment of Vice President of Marketing and Sales for Medical Market
28 4월 2005 - 9:00PM
PR Newswire (US)
ABAXIS Announces Appointment of Vice President of Marketing and
Sales for Medical Market UNION CITY, Calif., April 28
/PRNewswire-FirstCall/ -- Abaxis, Inc. (NASDAQ:ABAX), a medical
products company manufacturing point-of-care blood analysis
systems, announced today that it had appointed Lucien Ramondetta as
its new Vice President of Marketing and Sales for the Domestic
Medical Market. Prior to joining Abaxis, Mr. Ramondetta was the
Vice President of Sales and Marketing for the Medical Systems
Division of Philips Electronics, Ltd., a $38 billion manufacturer
of medical imaging equipment, lighting, electronics and appliances.
Prior to Philips Electronics, he was the Director of Global Sales
and Marketing of the Optoelectronics Division of Perkin Elmer
Corporation, responsible for managing medical, specialty
electronics and laser products. In addition, Mr. Ramondetta had a
long tenure in various sales and marketing management positions
with General Electric in both the Medical and Plastics divisions.
Clint Severson, Chairman, President and CEO, commented, "Lou brings
extensive experience in strategic planning, sales management and
process improvement and will be critical to our success as we
expand into the point-of-care medical market. We look forward to
his contributions as Abaxis works to increase its market share with
the Piccolo instrument." About Abaxis ABAXIS develops, manufactures
and markets portable blood analysis systems for use in any
patient-care setting to provide clinicians with rapid blood
constituent measurements. The system consists of a compact, 6.9
kilogram, portable analyzer and a series of 8-cm diameter
single-use plastic disks, called rotors or reagent discs that
contain all the reagents necessary to perform a fixed menu of
tests. The system can be operated with minimal training and perform
multiple tests on whole blood using either venous or fingerstick
samples. The system provides test results in less than 14 minutes
with the precision and accuracy equivalent to a clinical
laboratory. Contact: Clint Severson RCG Capital Markets Group Chief
Executive Officer Joe Dorame, Joe Diaz, Robert Blum ABAXIS, Inc.
480-675-0400 510-675-6500 DATASOURCE: Abaxis, Inc. CONTACT: Clint
Severson, Chief Executive Officer of ABAXIS, Inc., +1-510-675-6500;
or Joe Dorame, Joe Diaz or Robert Blum, all of RCG Capital Markets
Group, +1-480-675-0400, for ABAXIS, Inc.
Copyright
Abaxis, Inc. (delisted) (NASDAQ:ABAX)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Abaxis, Inc. (delisted) (NASDAQ:ABAX)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
Abaxis, Inc. (delisted) (나스닥)의 실시간 뉴스: 최근 기사 0
More Abaxis - Common Stock (MM) News Articles